Health
Nasal spray that treats Erectile Dysfunction in 5 minutes due in 2025
Nasal spray that treats Erectile Dysfunction in 5 minutes due in 2025
Health experts say they are developing a nasal spray Viagra that could be available as early as 2025. The nasal spray could treat erectile dysfunction up to 10 times faster than Viagra.
While Viagra was revolutionary when it hit shelves in the 1990s, but experts say it takes up to an hour to act, potentially ruining a spur-of-the-moment sexual encounter. The new experimental nasal spray treatment named Spontan, triggered an erection in as little as five minutes in early trials and could be available in the next two years.
Lee Rodne, who heads up the Australian company developing the spray, suggested it could be the most significant advancement in helping men keep an erection since Viagra emerged.
Millions of men in Nigeria suffer from erectile dysfunction, or the inability to get or maintain an erection during sexual activity. When a man gets an erection, the smooth muscles around the penis relax, allowing blood to flow into the region. In those with erectile dysfunction, this system may be disrupted by heart disease or emotional issues such as stress and anxiety limiting blood flow to the penis.
When aroused, the increase in blood flow allows a man to have a stronger erection. The drug must be taken orally and takes 30 minutes to an hour to kick in because it is absorbed by the digestive system.
READ ALSO:
- Appeal court upholds Maina’s eight-year sentence over N2.1bn Fraud
- We set shanties, criminal hideouts on fire at Alaba market – Lagos police
- Kenya sets up inquiry into cult deaths, leader to remain in prison
But doctors at Brisbane-based bio company LTR Pharma are now working on the spray drug that will use vardenafil, sold under the brand name Levitra. It is different from Viagra, which uses the drug sildenafil.
The treatment works faster than standard Viagra because it is absorbed directly into the bloodstream via the nose. Early proof-of-concept studies in California showed the treatment acted within five to 15 minutes. It is now moving into larger trials in Australia, which will start recruiting men in the second half of this year.
These trials are expected to start reporting results in the first half of next year. If successful, the company says it will apply to the Food and Drug Administration for approval of its drug. This is expected by 2025.
Lee Rodne, the executive chairman of LTR Pharma, said: “Our nasal delivery bypasses the digestive system so it really goes straight into the bloodstream and had an effect in five to 15 minutes.
“We expect it to be a lot more effective than oral tablets so that it works consistently and in a quicker and faster amount of time, so men don’t have to plan ahead and they don’t have variable results. We have very high confidence in the drug. This product has already had a small proof-of-concept clinical study in California that showed a fast-acting rapid onset effect.”
Erectile dysfunction (ED) is a very common clinical problem and can contribute to relationship breakdowns and mental health issues. It’s estimated the condition will affect around 40 percent of men, with the prevalence increasing with age.
Viagra works by relaxing the muscle cells in blood vessels supplying the penis, allowing more blood to flow into it. The drug also thins the blood making it flow more easily.
The drug, which has been manufactured by Pfizer since it first hit the market in 1998, was initially for older men dealing with erectile dysfunction.
While the drug has been approved by the Food and Drug Administration (FDA) and deemed okay for proper use by regulators, like all drugs, it can be dangerous if misused.
It can cause priapism, where a person has an erection that lasts for hours and causes permanent damage to the penis. It also has a few dangerous interactions with drugs for high cholesterol.
Nasal spray that treats Erectile Dysfunction in 5 minutes due in 2025
Vanguard
Health
Resident Doctors Threaten Fresh Nationwide Strike Over Unimplemented MoU
Resident Doctors Threaten Fresh Nationwide Strike Over Unimplemented MoU
The Nigerian Association of Resident Doctors (NARD) has warned of an imminent return to a nationwide strike, appealing to senior members of the medical profession to intervene as talks with the Federal Government stall.
In a statement issued on Sunday, NARD Secretary-General, Dr Shuaibu Ibrahim, said the association is on the verge of embarking on another Total and Indefinite Comprehensive Strike (TICS 2.0) due to the government’s failure to implement the Memorandum of Understanding (MoU) signed after the suspension of the last industrial action.
“I write to you at a critical moment for Nigeria’s health sector and the medical profession,” Ibrahim said while addressing respected medical elders.
According to him, the looming strike stems from the failure of the Federal Ministry of Health and the Federal Government to honour commitments freely entered into with NARD.
“The Nigerian Association of Resident Doctors stands on the brink of another nationwide industrial action, TICS 2.0, triggered by the failure of the Federal Ministry of Health and the Federal Government to honour the MoU,” he stated.
Ibrahim described the situation as distressing, noting that it reflects a breakdown of trust between the government and medical professionals. He said resident doctors had exercised restraint for months by suspending strikes and extending ultimatums without receiving any meaningful response.
READ ALSO:
- Zelenskyy Rejects Russia’s Claim of Drone Attack on Putin’s Residence, Warns of Escalation
- Amotekun Arrests 39 Suspected Terrorists Fleeing Sokoto After US Airstrikes
- Nigeria vs Uganda: Key Super Eagles Players Risk Suspension Ahead of AFCON Clash
He explained that after suspending a warning strike, NARD issued a two-week ultimatum, which elapsed without response, before extending it by 30 days and later by another seven days, all without results.
“Consequently, TICS 1.0 commenced, prompting limited engagement that culminated in the signing of an MoU with clear timelines,” he said.
However, Ibrahim noted that 31 days after the signing of the MoU, there has been no visible or substantive progress in its implementation.
“Resident doctors should not be blamed if industrial action resumes, having repeatedly demonstrated patience while government obligations remain unmet,” he added.
The NARD scribe said resident doctors, who form the backbone of service delivery in Nigeria’s tertiary hospitals, remain overworked and demoralised, warning that failure to respect agreements sends a dangerous signal to professionals in the health sector.
“When agreements addressing our welfare endorsed by the Federal Government are treated with levity, it sends a dangerous signal that sacrifice, dialogue and professionalism no longer count,” he said.
He therefore appealed to respected medical elders to prevail on the Federal Ministry of Health and the Federal Government to urgently implement the MoU.
The warning comes weeks after NARD suspended a 29-day nationwide strike that began on November 1, 2025, following an Extraordinary National Executive Council meeting. About 11,000 resident doctors across 91 teaching hospitals withdrew services during the strike, disrupting healthcare delivery nationwide.
The strike was suspended after the signing of an MoU addressing issues such as the reinstatement of Lokoja doctors, release of the Professional Allowance Table, payment of promotion and salary arrears, implementation of specialist allowance, and resolution of entry-level and membership certificate concerns.
NARD had warned that failure to meet the agreed timelines would result in a resumption of industrial action.
Resident Doctors Threaten Fresh Nationwide Strike Over Unimplemented MoU
Health
Brain Drain Deepens as 16,156 Nigerian Nurses Secure UK Licences Since 2017
Brain Drain Deepens as 16,156 Nigerian Nurses Secure UK Licences Since 2017
No fewer than 16,156 Nigerian-trained nurses and midwives have been licensed to practise in the United Kingdom between 2017 and September 30, 2025, according to latest data from the UK Nursing and Midwifery Council (NMC).
The figure, obtained from the NMC register, underscores the deepening brain drain in Nigeria’s healthcare sector, popularly referred to as “japa”, as skilled professionals continue to migrate in search of better pay, working conditions and career opportunities.
In an email response, the NMC, which regulates nurses and midwives in the UK, confirmed:
“As of 30 September 2025, there were 16,156 nurses on the register who were educated in Nigeria.”
The data shows a steady rise in migration. As of March 31, 2025, the number stood at 15,421, representing a 4.8 per cent increase within six months. Nigeria ranked as the third-highest source of foreign-trained nurses in the UK, behind India and the Philippines, according to the NMC’s March 2025 report.
READ ALSO:
- Sheikh Gumi Drags Two to Court Over Alleged Fake Threat Against Defence Minister
- Lagos Fire Service Battles Blaze at 25-Storey Great Nigeria Insurance House
- AFCON 2025: Tanzania Coach Gamondi Praises Players Despite 2–1 Defeat to Nigeria
Although international recruitment into the UK slowed across major source countries, including Nigeria, India and the Philippines, the report noted that the increase in UK-trained nurses has been too slow to offset the decline, resulting in slower overall growth on the NMC register.
The impact of this migration is being strongly felt at home. The 2025 Nigeria Health Statistics report, released by the Federal Ministry of Health and Social Welfare, revealed that 43,221 healthcare professionals—including doctors, nurses, pharmacists and medical laboratory scientists—left Nigeria between 2023 and 2024.
Specifically, the report showed that over 23,000 Nigerian nurses and midwives migrated abroad in 2024 alone. Their preferred destinations were the United States (8,613), United Kingdom (7,463), Canada (5,603), Saudi Arabia (1,231) and Ireland (989).
Highlighting the scale of the crisis, the Minister of State for Health and Social Welfare, Dr. Iziaq Salako, said Nigeria’s doctor-to-population ratio stands at 1:5,000, far below the World Health Organisation (WHO) recommendation of 1:600, while the nurse-to-population ratio is about 1:2,000, compared to the recommended 1:300.
Salako said the Federal Government is working to address the shortfall through strengthening primary healthcare, expanding the Health Workforce Registry, increasing training quotas, and implementing retention policies aimed at slowing the tide of healthcare migration.
Brain Drain Deepens as 16,156 Nigerian Nurses Secure UK Licences Since 2017
Health
NAFDAC Assures Nigerians: Locally Made Indomie Noodles Safe Amid French Recall Alert
NAFDAC Assures Nigerians: Locally Made Indomie Noodles Safe Amid French Recall Alert
The National Agency for Food and Drug Administration and Control (NAFDAC) has reassured the public that Indomie Noodles Vegetable Flavour is not registered or sold in Nigeria, following a recall alert issued by French health authorities.
In a press release on Sunday, NAFDAC clarified that the recall, initiated by Rappel Conso, France’s official consumer safety platform, involved undeclared allergens—milk and eggs—in the Vegetable Flavour variant, posing risks to individuals with allergies or intolerances. The agency emphasized that the product does not originate from Nigeria and is not approved for sale.
NAFDAC Director-General, Professor Mojisola Christianah Adeyeye, stated:
“The Indomie noodles vegetable flavour in question is not registered with NAFDAC for sale in Nigeria.”
READ ALSO:
- US, Nigeria Sign $5.1bn Health Pact to Expand Faith-Based Hospitals
- Oyo town agog as Alaafin Confers ‘Okanlomo of Yorubaland’ Title on Seyi Tinubu
- Akpabio Heads to Supreme Court Over Appeal Court Ruling on Natasha’s Suspension
The agency highlighted that noodle imports are on the Federal Government’s Import Prohibition List, making it illegal to bring such products into the country. To safeguard public health, NAFDAC has intensified nationwide surveillance, directing zonal directors, state coordinators, and Ports Inspection authorities to prevent any circulation of the recalled product.
The agency further assured that all Indomie noodles produced in Nigeria are locally manufactured, strictly regulated, and comply with Good Manufacturing Practice (GMP) standards. Consumers are advised to report any suspected sale or adverse reactions via NAFDAC’s toll-free number 0800-162-3322 or its e-reporting platforms.
In a separate statement, Indomie Nigeria confirmed that the company does not manufacture, import, or sell the Vegetable Flavour variant in Nigeria, stressing that all locally made Indomie noodles are safe for consumption. The company warned against purchasing noodles with unfamiliar packaging and urged reliance on official sources for verified information.
Both NAFDAC and Indomie Nigeria appealed for public calm, reiterating that Nigerian-produced Indomie noodles remain safe, unaffected, and compliant with regulatory standards.
NAFDAC Assures Nigerians: Locally Made Indomie Noodles Safe Amid French Recall Alert
-
metro3 days agoNiger Delta Crackdown: Army Seizes ₦150m Stolen Oil, Arrests 19 Suspects
-
Sports3 days agoCristiano Ronaldo Wins Best Middle East Player at 2025 Globe Soccer Awards in Dubai
-
Sports3 days agoAnthony Joshua injured as two die in fatal Lagos-Ibadan Expressway crash (plus photos)
-
metro2 days agoMrs. Regina Akume Urges SGF George Akume to Return to Christianity Amid New Marriage
-
metro2 days agoTwo Close Aides of Anthony Joshua Identified as Victims of Fatal Crash
-
metro2 days agoOgun Man Arrested After ₦4,000 Debt Dispute Claims Stepbrother’s Life
-
metro2 days agoMalami, Son, Wife Remanded Over ₦Billions Money Laundering Charges
-
metro2 days agoTinubu Condoles Anthony Joshua After Ogun Crash That Killed Two Associates

